Do cancer curvivors and metavivors have distinct needs for stress management intervention? Retrospective analysis of a mind-body survivorship program.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
06 Oct 2023
Historique:
received: 05 01 2023
accepted: 22 09 2023
medline: 23 10 2023
pubmed: 6 10 2023
entrez: 6 10 2023
Statut: epublish

Résumé

Cancer "curvivors" (completed initial curative intent treatment with surgery, radiation, chemotherapy, and/or other novel therapies) and "metavivors" (living with metastatic or chronic, incurable cancer) experience unique stressors, but it remains unknown whether these differences impact benefits from mind-body interventions. This study explored differences between curvivors and metavivors in distress (depression, anxiety, worry) and resiliency changes over the course of an 8-week group program, based in mind-body stress reduction, cognitive-behavioral therapy (CBT), and positive psychology. From 2017-2021, 192 cancer survivors (83% curvivors; 17% metavivors) completed optional online surveys of resiliency (CES) and distress (PHQ-8, GAD-7, PSWQ-3) pre- and post- participation in an established clinical program. Mixed effect regression models explored curvivor-metavivor differences at baseline and in pre-post change. Compared to curvivors, metavivors began the program with significantly more resilient health behaviors (B = 0.99, 95% CI[0.12, 1.86], p = .03) and less depression (B = -2.42, 95%CI[-4.73, -0.12], p = .04), with no other significant differences. Curvivors experienced significantly greater reductions in depression (curvivor-metavivor difference in strength of change = 2.12, 95% CI [0.39, 3.83], p = .02) over the course of the program, with no other significant differences. Neither virtual delivery modality nor proportion of sessions attended significantly moderated strength of resiliency or distress change. Metavivors entering this mind-body program had relatively higher well-being than did curvivors, and both groups experienced statistically comparable change in all domains other than depression. Resiliency programming may thus benefit a variety of cancer survivors, including those living with incurable cancer.

Identifiants

pubmed: 37801182
doi: 10.1007/s00520-023-08062-1
pii: 10.1007/s00520-023-08062-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

616

Subventions

Organisme : NCI NIH HHS
ID : K07CA211955
Pays : United States
Organisme : NCCIH NIH HHS
ID : K23 AT010157
Pays : United States
Organisme : NCCIH NIH HHS
ID : K23AT010157
Pays : United States
Organisme : NCI NIH HHS
ID : T32CA092203
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA211955
Pays : United States

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Institute of Medicine, National Research Council (2006) From cancer patient to cancer survivor: lost in transition. Hewitt M, Greenfield S, Stovall E (eds) The National Academies Press. https://doi.org/10.17226/11468
Aldaz BE, Treharne GJ, Knight RG, Conner TS, Perez D (2018) ‘It gets into your head as well as your body’: the experiences of patients with cancer during oncology treatment with curative intent. J Health Psychol 23:3–16. https://doi.org/10.1177/1359105316671185
doi: 10.1177/1359105316671185 pubmed: 27708126
Park ER, Li FP, Liu Y et al (2005) Health insurance coverage in survivors of childhood cancer: the Childhood Cancer Survivor Study. J Clin Oncol 23:9187–9197. https://doi.org/10.1200/JCO.2005.01.7418
doi: 10.1200/JCO.2005.01.7418 pubmed: 16361621
Hall DL, Mishel MH, Germino BB (2014) Living with cancer-related uncertainty: associations with fatigue, insomnia, and affect in younger breast cancer survivors. Support Care Cancer 22:2489–2495. https://doi.org/10.1007/s00520-014-2243-y
doi: 10.1007/s00520-014-2243-y pubmed: 24728586 pmcid: 6375671
Alfano CM, Rowland JH (2006) Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J 12:432–443. https://doi.org/10.1097/00130404-200609000-00012
doi: 10.1097/00130404-200609000-00012 pubmed: 17034679
Carreira H, Williams R, Müller M et al (2018) Associations between breast cancer survivorship and adverse mental health outcomes: a systematic review. J Natl Cancer Inst 110:1311–1327. https://doi.org/10.1093/jnci/djy177
doi: 10.1093/jnci/djy177 pubmed: 30403799 pmcid: 6292797
National Cancer Institute (2022) NOT-CA-22–077: notice of intent to publish a funding opportunity announcement for research to understand and address the survivorship needs of individuals living with advanced cancer (R01 Clinical Trial Optional). https://grants.nih.gov/grants/guide/notice-files/NOT-CA-22-077.html . Accessed 24 June 2022
Corneliussen-James D (2014) Speaking Out On Metastatic Breast Cancer. METAvivor: Metastatic Breast Cancer Research, Support, and Awareness. https://www.metavivor.org/blog/speaking-out-on-metastatic-breast-cancer . Accessed 19 May 2022
Berlinger N, Gusmano M (2011) Cancer chronicity: new research and policy challenges. J Health Serv Res Policy 16:121–123. https://doi.org/10.1258/jhsrp.2010.010126
doi: 10.1258/jhsrp.2010.010126 pubmed: 21378064
Park EM, Rosenstein DL (2014) Living with advanced cancer: unmet survivorship needs. N C Med J 75:279–282. https://doi.org/10.18043/ncm.75.4.279
doi: 10.18043/ncm.75.4.279 pubmed: 25046096
Harley C, Pini S, Bartlett YK, Velikova G (2015) Defining chronic cancer: patient experiences and self-management needs. BMJ Support Palliat Care 5:343–350. https://doi.org/10.1136/bmjspcare-2012-000200
doi: 10.1136/bmjspcare-2012-000200 pubmed: 26586683
Park ER, Peppercorn J, El-Jawahri A (2018) Shades of survivorship. J Natl Compr Canc Netw 16:1163–1165. https://doi.org/10.6004/jnccn.2018.7071
doi: 10.6004/jnccn.2018.7071 pubmed: 30323085
LeMay K, Wilson KG (2008) Treatment of existential distress in life threatening illness: a review of manualized interventions. Clin Psychol Rev 28:472–493. https://doi.org/10.1016/j.cpr.2007.07.013
doi: 10.1016/j.cpr.2007.07.013 pubmed: 17804130
Frick MA, Vachani CC, Bach C et al (2017) Survivorship and the chronic cancer patient: patterns in treatment-related effects, follow-up care, and use of survivorship care plans. Cancer 123:4268–4276. https://doi.org/10.1002/cncr.30862
doi: 10.1002/cncr.30862 pubmed: 28654153
Antoni MH, Lechner S, Diaz A et al (2009) Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer. Brain Behav Immun 23:580–591. https://doi.org/10.1016/j.bbi.2008.09.005
doi: 10.1016/j.bbi.2008.09.005 pubmed: 18835434
Carlson LE, Zelinski E, Toivonen K et al (2017) Mind-body therapies in cancer: what is the latest evidence? Curr Oncol Rep 19:67. https://doi.org/10.1007/s11912-017-0626-1
doi: 10.1007/s11912-017-0626-1 pubmed: 28822063
Hall DL, Luberto CM, Philpotts LL et al (2018) Mind-body interventions for fear of cancer recurrence: a systematic review and meta-analysis. Psychooncology 27:2546–2558. https://doi.org/10.1002/pon.4757
doi: 10.1002/pon.4757 pubmed: 29744965 pmcid: 6488231
Antoni MH, Moreno PI, Penedo FJ (2023) Stress management interventions to facilitate psychological and physiological adaptation and optimal health outcomes in cancer patients and survivors. Annu Rev Psychol 74:423–455. https://doi.org/10.1146/annurev-psych-030122-124119
doi: 10.1146/annurev-psych-030122-124119 pubmed: 35961041
Finkelstein-Fox L, Rasmussen AW, Hall DL et al (2022) Testing psychosocial mediators of a mind-body resiliency intervention for cancer survivors. Support Care Cancer 30:5911–5919. https://doi.org/10.1007/s00520-022-07022-5
doi: 10.1007/s00520-022-07022-5 pubmed: 35386004 pmcid: 8986336
Perez GK, Walsh EA, Quain K, Abramson JS, Park ER (2021) A virtual resiliency program for lymphoma survivors: helping survivors cope with post-treatment challenges. Psychol Health 36:1352–1367. https://doi.org/10.1080/08870446.2020.1849699
doi: 10.1080/08870446.2020.1849699 pubmed: 33251861
Hall DL, Park ER, Cheung T, Davis RB, Yeh GY (2020) A pilot mind-body resiliency intervention targeting fear of recurrence among cancer survivors. J Psychosom Res 137:110215. https://doi.org/10.1016/j.jpsychores.2020.110215
doi: 10.1016/j.jpsychores.2020.110215 pubmed: 32818720 pmcid: 7873146
Park ER, Luberto CM, Chad-Friedman E et al (2021) A comprehensive resiliency framework: theoretical model, treatment, and evaluation. Glob Adv Health Med 10:21649561211000304. https://doi.org/10.1177/21649561211000306
doi: 10.1177/21649561211000306 pubmed: 34377598 pmcid: 8327002
Park ER, Traeger L, Vranceanu AM et al (2013) The development of a patient-centered program based on the relaxation response: the Relaxation Response Resiliency Program (3RP). Psychosomatics 54:165–174. https://doi.org/10.1016/j.psym.2012.09.001
doi: 10.1016/j.psym.2012.09.001 pubmed: 23352048
Lazarus R, Folkman S (1984) Stress, Appraisal, and Coping. Springer, New York
Hall DL, Yeh GY, O’Cleirigh C et al (2022) A multi-step approach to adapting a mind-body resiliency Intervention for Fear of Cancer Recurrence and Uncertainty in Survivorship (IN FOCUS). Glob Adv Health Med 11:21649561221074690
doi: 10.1177/21649561221074690 pubmed: 35237466 pmcid: 8883302
Gonzalez A, Shim M, Mahaffey B et al (2019) The Relaxation Response Resiliency Program (3RP) in patients with headache and musculoskeletal pain: a retrospective analysis of clinical data. Pain Manag Nurs 20:70–74. https://doi.org/10.1016/j.pmn.2018.04.003
doi: 10.1016/j.pmn.2018.04.003 pubmed: 29773354
Greenberg J, Lin A, Zale EL et al (2019) Development and early feasibility testing of a mind-body physical activity program for patients with heterogeneous chronic pain; the GetActive study. J Pain Res 12:3279–3297. https://doi.org/10.2147/JPR.S222448
doi: 10.2147/JPR.S222448 pubmed: 31849515 pmcid: 6912090
Luberto CM, Wang A, Li R et al (2022) Videoconference-delivered mind-body resiliency training in adults with congenital heart disease: a pilot feasibility trial. Int J Cardiol Congenit Heart Dis 7:100324. https://doi.org/10.1016/j.ijcchd.2022.100324
doi: 10.1016/j.ijcchd.2022.100324
Denninger JW, Laubach JP, Yee AJ et al (2017) Psychosocial effects of the relaxation response resiliency program (SMART-3RP) in patients with MGUS and smoldering multiple myeloma: a waitlist controlled randomized clinical trial. J Clin Oncol 35:10051–10051. https://doi.org/10.1200/JCO.2017.35.15_suppl.10051
doi: 10.1200/JCO.2017.35.15_suppl.10051
Vranceanu AM, Merker VL, Plotkin SR, Park ER (2014) The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study. J Neurooncol 120:103–109. https://doi.org/10.1007/s11060-014-1522-2
doi: 10.1007/s11060-014-1522-2 pubmed: 25022450
Traeger L, Styklunas GM, Park EY et al (2022) Promoting resilience and flourishing among older adult residents in community living: a feasibility study. Gerontologist 62:1507–1518. https://doi.org/10.1093/geront/gnac031
doi: 10.1093/geront/gnac031 pubmed: 35235940
Tedeschi RG, Calhoun LG (1996) The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress 9:455–471. https://doi.org/10.1002/jts.2490090305
doi: 10.1002/jts.2490090305 pubmed: 8827649
Spitzer RL, Kroenke K, Williams JB, Lowe B (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092–1097. https://doi.org/10.1001/archinte.166.10.1092
doi: 10.1001/archinte.166.10.1092 pubmed: 16717171
Zeynalova N, Schimpf S, Setter C et al (2019) The association between an anxiety disorder and cancer in medical history. J Affect Disord 246:640–642. https://doi.org/10.1016/j.jad.2018.12.019
doi: 10.1016/j.jad.2018.12.019 pubmed: 30611061
Kroenke K, Strine TW, Spitzer RL et al (2009) The PHQ-8 as a measure of current depression in the general population. J Affect Disord 114:163–173. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
doi: 10.1046/j.1525-1497.2001.016009606.x pubmed: 18752852
Gonzalez P, Castañeda SF, Dale J et al (2014) Spiritual well-being and depressive symptoms among cancer survivors. Support Care Cancer 22:2393–2400. https://doi.org/10.1007/s00520-014-2207-2
doi: 10.1007/s00520-014-2207-2 pubmed: 24691887 pmcid: 4324591
Meyer TJ, Miller ML, Metzger RL, Borkovec TD (1990) Development and validation of the Penn State Worry Questionnaire. Behav Res Ther 28:487–495. https://doi.org/10.1016/0005-7967(90)90135-6
doi: 10.1016/0005-7967(90)90135-6 pubmed: 2076086
Berle D, Starcevic V, Moses K et al (2011) Preliminary validation of an ultra-brief version of the Penn State Worry Questionnaire. Clin Psychol Psychother 18:339–346. https://doi.org/10.1002/cpp.724
doi: 10.1002/cpp.724 pubmed: 20806422
Wu SM, Schuler TA, Edwards MC, Yang HC, Brothers BM (2013) Factor analytic and item response theory evaluation of the Penn State Worry Questionnaire in women with cancer. Qual Life Res 22:1441–1449. https://doi.org/10.1007/s11136-012-0253-0
doi: 10.1007/s11136-012-0253-0 pubmed: 22903634
Hayes AF, Coutts JJ (2020) Use omega rather than Cronbach’s alpha for estimating reliability. But…. Commun Methods Meas 14:1–24. https://doi.org/10.1080/19312458.2020.1718629
doi: 10.1080/19312458.2020.1718629
Bates D, Mächler M, Bolker B, Walker S (2015) Fitting linear mixed-effects models using lme4. J Stat Softw 67:1–48. https://doi.org/10.18637/jss.v067.i01
doi: 10.18637/jss.v067.i01
Rubin DB (1976) Inference and missing data. Biometrika 63:581–592. https://doi.org/10.1093/biomet/63.3.581
doi: 10.1093/biomet/63.3.581
Heron-Speirs HA, Harvey ST, Baken DM (2012) Moderators of psycho-oncology therapy effectiveness: addressing design variable confounds in meta-analysis. Clin Psychol Sci Pract 19:49–71. https://doi.org/10.1111/j.1468-2850.2012.01274.x
doi: 10.1111/j.1468-2850.2012.01274.x
Schneider S, Moyer A, Knapp-Oliver S et al (2010) Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: a meta-analysis. J Behav Med 33:1–14. https://doi.org/10.1007/s10865-009-9227-2
doi: 10.1007/s10865-009-9227-2 pubmed: 19784868
Saracino RM, Aytürk E, Cham H et al (2020) Are we accurately evaluating depression in patients with cancer? Psychol Assess 32:98–107. https://doi.org/10.1037/pas0000765
doi: 10.1037/pas0000765 pubmed: 31393150
Greenberg J, Braun TD, Schneider ML et al (2018) Is less more? A randomized comparison of home practice time in a mind-body program. Behav Res Ther 111:52–56. https://doi.org/10.1016/j.brat.2018.10.003
doi: 10.1016/j.brat.2018.10.003 pubmed: 30312895 pmcid: 6538938
Flanagin A, Frey T, Christiansen SL, AMA Manual of Style Committee (2021) Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 326:621–627. https://doi.org/10.1001/jama.2021.13304
doi: 10.1001/jama.2021.13304 pubmed: 34402850

Auteurs

Lucy Finkelstein-Fox (L)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA. lfinkelsteinfox@mgh.harvard.edu.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA. lfinkelsteinfox@mgh.harvard.edu.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA. lfinkelsteinfox@mgh.harvard.edu.

Cayley C Bliss (CC)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.

Autumn W Rasmussen (AW)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.

Daniel L Hall (DL)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Areej El-Jawahri (A)

Department of Psychology, University of Miami, Coral Gables, FL, USA.
Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Giselle K Perez (GK)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Lara N Traeger (LN)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Department of Psychology, University of Miami, Coral Gables, FL, USA.

Amy H Comander (AH)

Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Jeffrey Peppercorn (J)

Massachusetts General Hospital Cancer Center, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Reid Anctil (R)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.

Elise Noonan (E)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.

Elyse R Park (ER)

Department of Psychiatry, Massachusetts General Hospital, 100 Cambridge St., Suite 1600, Boston, MA, 02114, USA.
Health Promotion and Resiliency Intervention Research (HPRIR) Program, Massachusetts General Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Department of Medicine, Harvard Medical School, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH